1Deloach JR,Andrews K,Naqi A.Targeting of mycotoxins to reticuloendothelial system of mice with carrier erythrocytes[J].Biotechnol Appl Biochem,1988,10(2):154.
3Lejeune A,Moorjani M,Gicquaud C,et al.Nanoerythrosome,a new derivative of erythrocyte ghost:preparation and antineoplastic potential as drug carrier for daunorubicin[J].Anticancer Res,1994,14(3A):915.
5Tonetti M,Gasparini A,Giovine M,et al.Interaction of carboplatin with carrier human erythrocytes[J].Biotechnol Appl Biochem,1992,15(3):267.
6DeLoach JR,Andrews K,Sheffield CL.Encapsulation of interleukin-2 in murine erythrocytes and subsequent deposition in mice receiving a subcutaneous injection[J].Biotechnol Appl Biochem,1988,10(2):183.
8Kruse CA.Ultrastructural observations on the transformations of osmotically stressed and electrically pulsed red cell carriers at stages during their formation[J].Blood Cells,1991,17(1):177.
9Mishra PR,Jain NK.Surface modified methotrexate loaded erythrocytes for enhanced macrophage uptake[J].J Drug Target,2000,8(4):217.
10Mishra PR,Jain NK.Biotinylated methotrexate loaded erythrocytes for enhanced liver uptake."A study on the rate"[J].Inter J Pharm,2002,231(2):145.
二级参考文献17
1程根林，中国输血杂志，1996年，4期，150页
2李晓，中华血液学杂志，1990年，11卷，119页
3杨秀芬，中华血液学杂志，1990年，11期，525页
4Garin MI,Lopez RM,Sanz S,et al. Erythrocytes as carriers for recombinant human erythropoietin[J]. Pharm Res,1996,13(6):869-874.
5Sanz S,Lizano C,Luque J,et al. In vitro and in vivo study of glutamate dehydrogenase encapsulated into mouse erythrocytes by a hypotonic dialysis procedure[J]. Life Sci,1999,65(26):2781-2789.
6Kravtzoff R,Ropars C,Laguerre M,et al. Erythrocytes as carriers for L-asparaginase. Methodological and mouse in-vivo studies[J]. J Pharm Pharmacol,1990,42(7):473-476.
7O'Byrne KJ,Steward WP. The promise of improved drug delivery[J]. Clin Sci (London),1999, 96(2):127-128.
8Jain S,Jain NK. Preparation,characterization and pharmaceutical potential of engineered erythrocytes[J]. Pharmazie,1998,53(1):5-14.
9Tajerzadeh H,Hamidi M. Evaluation of hypotonic preswelling method for encapsulation of enalaprilat in intact human erythrocytes[J]. Drug Dev Ind Pharm,2000,26(12):1247-1257.
10Rechsteiner MC. Uptake of proteins by red blood cells[J]. Exptl Cell Res,1975,93(2):487-492.
3Rask C,Albertioni F,Bentzen SM,et al.Clinical and pharmacokinetic risk factors for high dose methotrexate induced toxicity in children with acute lymphoblastic leukemia--a logistic regression analysis[J].Acta Oncol,1998,37(3):277-84.
4Boffa MJ.Methotrexate for psoriasis:current European practice.A postal survey[J].J Eur Acad Dermatol Venereol,2005,19(2):196-202.
5Deloach JR,Widnell CIhler GM.Phagocytosis of enzyme-containing carrier erythrocytes by macrophages[J].J App Biochem,1979,1(1-2):95-103.
6Kruse CA.Ultrastructural observations on the transformations of osmotically stressed and electrically pulsed red cell carriers at stages during their formation[J].Blood Cells,1991,17(1):177.
7Yuan SH,Ge WH,Huo J,Wang XH.Slow release properties and liver targeting characteristics of methotrexate erythrocyte carriers[J].Fundam Clin Pharmacol,2009,23(2):189-96.
8Tian HH,Cronstein BN.Understanding the mechanisms of action of methotrexate implications for the treatment of rheumatoid arthritis[J].Bull NYU Hosp Jt Dis,2007,65(3):168-73.
9Hasko G,Cronstein BN.Adenosine:an endogenous regulator of innate immunity[J].Trends Immunol,2004,25(1):33-9.
10Montesinos MC,Takedachi M,Thompson LF,et al.The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'nucleotidase[J].Arthtis Rheum,2007,56(5):1440-5.
